Physician profile
Derek Lee Snook
NPI 1508859752
$3,439.02
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,673 · 2020: $23.83 · 2021: $20.96 · 2022: $242 · 2023: $33.04 · 2024: $1,222 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,157 · Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,156.51 |
| Food and Beverage | $323.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,617.00 | 2019 | |
| Aesculap Implant Systems, LLC | $1,201.51 | 2024 | Activl |
| Medacta USA, INC. | $218.10 | 2022-2025 | Gmk Sphere |
| Becton, Dickinson and Company | $147.22 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $65.66 | 2025 | Iovera, Zilretta, Exparel |
| Pacira Therapeutics, INC. | $36.06 | 2020-2021 | |
| Medtronic, INC. | $35.75 | 2023-2024 | Intellis Adaptivestim, Aquamantys(Tm) |
| Kci USA, INC. | $21.40 | 2019 | |
| Ethicon US, LLC | $20.45 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.64 | 2025 | |
| Si-Bone, INC. | $17.87 | 2023 | |
| Abbott Laboratories | $15.97 | 2022 | |
| Bard Access Systems, INC. | $13.66 | 2019 | |
| Spr Therapeutics, INC | $8.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Snook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.